Evaxion expands and refocuses R&D pipeline with EVX-05, an AI-designed off-the-shelf brain cancer vaccine program
Go back to Evaxion expands and refocuses R&D pipeline with EVX-05, an AI-designed off-the-shelf brain cancer vaccine program| (NASDAQ: EVAX) | Delayed: 3.17 +0.05 (1.60%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $3.12 | 52 Week High | $ | |||
| Open | $3.12 | 52 Week Low | $ | |||
| Day High | $3.31 | P/E | N/A | |||
| Day Low | $3.10 | EPS | $ | |||
| Volume | 63,850 | |||||
